Please provide your email address to receive an email when new articles are posted on . Weight gain after ART initiation is associated with long-term risks of cardiovascular and metabolic diseases.

Among patients living with HIV receiving antiretroviral therapy (ART), 22% reported experiencing undesired weight gain in the past 12 months. Switching ART regimens and having a BMI indicative of ...

Weight gain associated with integrase strand transfer inhibitor-based antiretroviral therapy (ART) may be mitigated or reversed over time by switching to protease inhibitor-based ART. For patients ...

Researchers assessed the relationship between changes in weight after antiretroviral therapy initiation and the risk for cardiometabolic disease in patients with HIV. Patients with HIV infection who ...

Adults with HIV and obesity who switched from an antiretroviral therapy (ART) regimen with an integrase strand transfer inhibitor (INSTI) and tenofovir alafenamide to doravirine with or without ...